Authors: A. Umar, A. Omer, D. Jerene, D. Lemma, M. Godebo, KNCV Tuberculosis Foundation.
Ethiopia made significant strides to improve management of latent tuberculosis infection (LTBI). The recent endorsement of three-month regimen of INH and rifapentine (3HP) and 3RH is such an example. In preparation to support the roll out these new recommendations, we reviewed the rate of IPT initiation for eligible under five children in two regions of Ethiopia.
“25-37% of bacteriologically confirmed index TB patients were living with under-five children. Of eligible children screened for TB, only 56% were put on preventive therapy.”
- This study was conducted in the Southern and Addis Ababa regions of Ethiopia
- We collected and analyzed secondary data for the period Oct 2016 – Sept 2017
- We extracted data from the standard of Care led mentorship database which captured important variables related to contact screening and provision of preventive therapy.
- 25-37% of bacteriologically confirmed index pulmonary TB patients were living with <5 yr children
- Of 14716 contacts screened, 11.2% were children
- 93% of <5-year household contacts were screened for TB but the diagnosis of TB in a one-time contact TB screening was < 0.15%.
- Of those screened, 92% were eligible for TB Preventive therapy (TPT) but only 56% received it.
Despite high rates of household contact screening, the rate of TPT initiation was low and information on TPT completion rate is lacking. Further interventions are needed to improve the TPT initiation rate and documentation of TPT completion rates.
|# of HH contact registered||12,727||100%||2,765||100%||15,492||100%|
|# of HH contact TB screened – all ages||12,102||95%||2,614||95%||14,716||95%|
|# of HH contact children age < 5 yr||1,417||11.7%||233||8.9%||1,650||11.2%|
|# of children contacts < 5 yrscreened for TB||1,314||93%||220||94%||1,534||93%|
|# of < 5 yrcontacts eligible for IPT||1,305||92%||216||93%||1,521||92%|
|# of eligible children < 5 yr put on IPT||731||56%||116||53%||847||56%|
This Project is supported by the Stop TB Partnership’s TB REACH initiative and is funded by the Government of Canada, the Bill & Melinda Gates Foundation, and the United States Agency for International Development.